Health care providers want this information before prescribing the HIV prevention, PrEP, to adolescents, study finds

HIV infections among adolescents and young adults continue to be at high levels, with Americans between the ages of 13 and 24 accounting for approximately 20% of all new HIV infections in 2019. However, uptake of a preventive regimen known as pre-exposure prophylaxis (PrEP) in this group remains low.

Related Keywords

Texas ,United States ,Americans ,Christopher Owens ,Department Of Health Behavior ,Texasam University School Of Nursing ,Drug Administration ,Health Behavior ,Public Health ,Primary Care Provider Information Needs ,Prescribing Adolescents ,Exposure Prophylaxis ,